C Cerulean Pharma Inc.: management transactions · United States · SEC (Form 4) Browse the full insider trade history of Cerulean Pharma Inc., a publicly traded company based in United States. Shares trade on US US, under the authority of SEC (Form 4). The latest transaction was disclosed on 12 February 2016 (Acquisition). Among the most active insiders: WALT DAVID R. The full history is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 12 February 2016
All Executives29 Thresholds0 Prospectus0 Other0
Declarations 29 total
▲ Director · Executives · 10 Feb 2016
4,500 shares Common Stock SEC:0001209191-16-098014:0
Ideal exit: 6 Nov 2016 (T+270) ▲ Director · Executives · 11 Feb 2016
4,350 shares Common Stock SEC:0001209191-16-098014:1
Ideal exit: 7 Nov 2016 (T+270) ▲ Director · Executives · 8 Feb 2016
4,500 shares Common Stock SEC:0001209191-16-097270:0
Ideal exit: 4 Nov 2016 (T+270) ▲ Director · Executives · 9 Feb 2016
4,500 shares Common Stock SEC:0001209191-16-097270:1
Ideal exit: 5 Nov 2016 (T+270) ▲ Director · Executives · 5 Feb 2016
4,500 shares Common Stock SEC:0001209191-16-096365:1
Ideal exit: 1 Nov 2016 (T+270) ▲ Director · Executives · 4 Feb 2016
4,063 shares Common Stock SEC:0001209191-16-096365:0
Ideal exit: 31 Oct 2016 (T+270) ▲ Director · Executives · 2 Feb 2016
4,395 shares Common Stock SEC:0001209191-16-095726:0
Ideal exit: 29 Oct 2016 (T+270) ▲ Director · Executives · 3 Feb 2016
4,018 shares Common Stock SEC:0001209191-16-095726:1
Ideal exit: 30 Oct 2016 (T+270) ▲ Director · Executives · 29 Jan 2016
1,200 shares Common Stock SEC:0001209191-16-094706:0
Ideal exit: 25 Oct 2016 (T+270) ▲ Director · Executives · 1 Feb 2016
4,500 shares Common Stock SEC:0001209191-16-094706:1
Ideal exit: 28 Oct 2016 (T+270) ▲ Director · Executives · 27 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-094149:0
Ideal exit: 23 Oct 2016 (T+270) ▲ Director · Executives · 28 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-094149:1
Ideal exit: 24 Oct 2016 (T+270) ▲ Director · Executives · 25 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-093783:0
Ideal exit: 21 Oct 2016 (T+270) ▲ Director · Executives · 26 Jan 2016
4,300 shares Common Stock SEC:0001209191-16-093783:1
Ideal exit: 22 Oct 2016 (T+270) ▲ Director · Executives · 21 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-093420:0
Ideal exit: 17 Oct 2016 (T+270) ▲ Director · Executives · 22 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-093420:1
Ideal exit: 18 Oct 2016 (T+270) ▲ Director · Executives · 19 Jan 2016
4,400 shares Common Stock SEC:0001209191-16-092885:0
Ideal exit: 15 Oct 2016 (T+270) ▲ Director · Executives · 20 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-092885:1
Ideal exit: 16 Oct 2016 (T+270) ▲ Director · Executives · 14 Jan 2016
4,400 shares Common Stock SEC:0001209191-16-092049:0
Ideal exit: 10 Oct 2016 (T+270) ▲ Director · Executives · 15 Jan 2016
4,172 shares Common Stock SEC:0001209191-16-092049:1
Ideal exit: 11 Oct 2016 (T+270) ▲ Director · Executives · 12 Jan 2016
4,300 shares Common Stock SEC:0001209191-16-091409:0
Ideal exit: 8 Oct 2016 (T+270) ▲ Director · Executives · 13 Jan 2016
4,384 shares Common Stock SEC:0001209191-16-091409:1
Ideal exit: 9 Oct 2016 (T+270) ▲ Director · Executives · 8 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-090953:0
Ideal exit: 4 Oct 2016 (T+270) ▲ Director · Executives · 11 Jan 2016
4,355 shares Common Stock SEC:0001209191-16-090953:1
Ideal exit: 7 Oct 2016 (T+270) ▲ Director · Executives · 6 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-090585:0
Ideal exit: 2 Oct 2016 (T+270) 25 of 29 declarations
Load more (4 remaining)